Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Freeport-McMoRan Inc (FCX) vs Indivior Pharmaceuticals Inc. Common Stock (INDV) Price & Performance

Freeport-McMoRan IncTrade
Indivior Pharmaceuticals Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Freeport-McMoRan Inc vs Indivior Pharmaceuticals Inc. Common Stock — how do they compare? Freeport-McMoRan Inc trades at $68.61 (market cap $99.98B), while Indivior Pharmaceuticals Inc. Common Stock trades at $34.3 (market cap $4.18B). The key difference: Freeport-McMoRan Inc is far larger — about 23.9× Indivior Pharmaceuticals Inc. Common Stock's market cap, and Freeport-McMoRan Inc pays a 0.86% dividend while Indivior Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Freeport-McMoRan Inc for 70 Days and Indivior Pharmaceuticals Inc. Common Stock for 0 Days on average.

FCXINDV
Market Cap
$99.98B$4.18B
Volume
12,433,7331,819,746
Sector
Basic MaterialsHealth
52-Week High
$79.91$41.83
52-Week Low
$38.65$24.09
Typical Hold Time
70 Days0 Days
Enterprise Value
$106.25B$4.47B
Dividend Yield
0.86%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Freeport-McMoRan Inc

FCX trades at $72.42, down 1.19% today, with a bullish technical signal from moving averages and a consensus analyst price target of $73.50. The company has beaten earnings estimates for the last three quarters, with Q3 2026 results pending. Revenue reached $25.92B in 2025, and net income margin improved to 11.38%. Strong cash flow from operations of $5.61B supports dividend payments and growth projects amid rising copper demand driven by AI and data centers.

FCX presents a positive outlook with robust fundamentals and favorable copper market dynamics, but faces risks from cost pressures and regulatory scrutiny. Earnings growth and expansion initiatives are key catalysts, while investor sentiment remains bullish based on analyst ratings.

Indivior Pharmaceuticals Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FCX
19% Buy81% Sell
Avg holding period · 70 Days
INDV
100% Buy0% Sell
Avg holding period · 0 Days

About Freeport-McMoRan Inc

Freeport-McMoRan Inc is an international mining company. It operates geographically diverse assets with proven and probable mineral reserves of copper, gold and molybdenum. The company's portfolio of assets includes the Grasberg minerals district in Indonesia

Read more on FCX →

About Indivior Pharmaceuticals Inc. Common Stock

Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.

Read more on INDV →